Hemab Therapeutics (COAG.US) Shareholders - Institutional Holders, Major Shareholders & Insiders | Longbridge

Shareholder Type

VC/PE firms48.62%
Institutions44.14%
Hedge funds6.98%
Individuals & Insiders0.26%

Major Shareholders

Major Shareholders Latest
Shareholder
RA Capital Management, L.P.	16.72%	7.81M	0.91%	+2.97M	06/30/2026
Access Biotechnology	10.44%	4.88M	3.32%	+1.10M	05/04/2026
Novo Holdings A/S	8.95%	4.18M	6.28%	+0	06/30/2026
FMR LLC	7.92%	3.70M	--	+3.70M	06/30/2026
Capital Research and Management Company	7.72%	3.60M	0.15%	+1.45M	06/30/2026
Deep Track Capital, LP	7.71%	3.60M	0.28%	+1.41M	06/30/2026
Avoro Capital Advisors LLC	7.06%	3.30M	0.51%	+1.50M	06/30/2026
Sofinnova Partners SAS	5.38%	2.51M	3.27%	+137.50K	06/30/2026
Artal Group S.A.	4.91%	2.30M	0.45%	+208.20K	08/05/2026
Odlander, Fredrikson & Co. AB	4.06%	1.89M	2.85%	+0	05/01/2026
Bain Capital Life Sciences Investors, LLC	3.53%	1.65M	--	+1.65M	06/30/2026
JP Morgan Asset Management	2.43%	1.13M	--	+1.13M	06/30/2026
Vanguard Capital Management, LLC	1.91%	893.26K	--	+893.26K	06/30/2026
T. Rowe Price Group, Inc.	1.60%	746.04K	--	+746.04K	06/30/2026
Driehaus Capital Management LLC	1.53%	715.79K	--	+715.79K	06/30/2026
Rock Springs Capital Management LP	1.23%	575.43K	--	+575.43K	06/30/2026
Bellevue Asset Management AG	1.18%	550.00K	--	+550.00K	06/30/2026
Citadel Advisors LLC	1.12%	523.45K	--	+523.45K	06/30/2026
BlackRock, Inc.	0.61%	283.83K	--	+283.83K	06/30/2026
Deerfield Management Company, L.P.	0.59%	275.00K	--	+275.00K	06/30/2026